Entity Common Stock, Shares Outstanding of BioSig Technologies, Inc. from Q2 2014 to Q3 2025

Taxonomy & unit
dei: shares
Description
Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument.
Summary
BioSig Technologies, Inc. quarterly Entity Common Stock, Shares Outstanding history and change rate from Q2 2014 to Q3 2025.
  • BioSig Technologies, Inc. Entity Common Stock, Shares Outstanding for the quarter ending 13 Nov 2025 was 39.5M shares, a 129% increase year-over-year.
Entity Common Stock, Shares Outstanding, Quarterly (shares)
Entity Common Stock, Shares Outstanding, YoY Quarterly Change (%)

BioSig Technologies, Inc. Quarterly Entity Common Stock, Shares Outstanding (shares)

Period Value YoY Chg Change % Date Report Filed
Q3 2025 39.5M +22.3M +129% 13 Nov 2025 10-Q 14 Nov 2025
Q2 2025 31.4M +15.1M +93% 14 Aug 2025 10-Q 15 Aug 2025
Q1 2025 24.3M +13.1M +117% 14 Apr 2025 10-K 15 Apr 2025
Q3 2024 17.2M -70.9M -80.4% 14 Nov 2024 10-Q 14 Nov 2024
Q2 2024 16.3M -58.6M -78.3% 13 Aug 2024 10-Q 14 Aug 2024
Q1 2024 11.2M -55.7M -83.3% 15 Apr 2024 10-K 16 Apr 2024
Q3 2023 88.1M +40.1M +83.5% 13 Nov 2023 10-Q 14 Nov 2023
Q2 2023 74.9M +35.3M +89.2% 13 Aug 2023 10-Q 14 Aug 2023
Q1 2023 66.9M +28.4M +74% 30 Mar 2023 10-K 31 Mar 2023
Q3 2022 48M 14 Nov 2022 10-Q 14 Nov 2022
Q2 2022 39.6M +4.69M +13.4% 16 May 2022 10-Q 16 May 2022
Q1 2022 38.4M +6.63M +20.9% 30 Mar 2022 10-K 31 Mar 2022
Q4 2021 35.3M 15 Nov 2021 10-Q 15 Nov 2021
Q2 2021 34.9M +5.28M +17.8% 11 Aug 2021 10-Q 11 Aug 2021
Q1 2021 31.8M +5.82M +22.4% 12 Mar 2021 10-K 15 Mar 2021
Q3 2020 30.2M +8.08M +36.4% 05 Nov 2020 10-Q 05 Nov 2020
Q2 2020 29.6M +7.89M +36.3% 06 Aug 2020 10-Q/A 28 Aug 2020
Q1 2020 26M +5.75M +28.5% 13 Mar 2020 10-K 13 Mar 2020
Q3 2019 22.2M +5.51M +33.1% 23 Oct 2019 10-Q 23 Oct 2019
Q2 2019 21.8M -15.6M -41.7% 31 Jul 2019 10-Q 31 Jul 2019
Q1 2019 20.2M -9.79M -32.6% 15 Apr 2019 10-Q 15 Apr 2019
Q3 2018 16.7M -11.6M -41.1% 02 Nov 2018 10-Q 02 Nov 2018
Q2 2018 37.3M +11.4M +44% 27 Jul 2018 10-Q 27 Jul 2018
Q1 2018 30M +5.91M +24.5% 27 Feb 2018 10-K 27 Feb 2018
Q3 2017 28.3M +7.36M +35.1% 09 Nov 2017 10-Q 09 Nov 2017
Q2 2017 25.9M +5.45M +26.6% 10 Aug 2017 10-Q 10 Aug 2017
Q1 2017 24.1M +6.84M +39.7% 30 Mar 2017 10-K 11 Apr 2017
Q3 2016 21M +5.46M +35.3% 14 Nov 2016 10-Q 14 Nov 2016
Q2 2016 20.5M +5.77M +39.2% 12 Aug 2016 10-Q 12 Aug 2016
Q1 2016 17.3M +3.62M +26.5% 14 Mar 2016 10-K 14 Mar 2016
Q3 2015 15.5M +4.48M +40.7% 13 Nov 2015 10-Q 13 Nov 2015
Q2 2015 14.7M +4.89M +49.7% 28 Jul 2015 10-Q 28 Jul 2015
Q1 2015 13.6M 01 May 2015 10-Q 01 May 2015
Q3 2014 11M 17 Oct 2014 10-Q 17 Oct 2014
Q2 2014 9.82M 28 Jul 2014 10-Q 28 Jul 2014
* An asterisk sign (*) next to the value indicates that the value is likely invalid.